Biomarkers in colorectal cancer: Current clinical utility and future perspectives
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
Authors
Keywords
-
Journal
World Journal of Clinical Cases
Volume 6, Issue 15, Pages 869-881
Publisher
Baishideng Publishing Group Inc.
Online
2018-12-06
DOI
10.12998/wjcc.v6.i15.869
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development
- (2018) Luca Falzone et al. Aging-US
- Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models
- (2018) Janneke F. Linnekamp et al. CELL DEATH AND DIFFERENTIATION
- Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer
- (2018) Akira Okita et al. Oncotarget
- Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
- (2017) Antonia R. Sepulveda et al. JOURNAL OF CLINICAL ONCOLOGY
- Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
- (2017) Claudio Isella et al. Nature Communications
- APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review
- (2017) Tie-Jun Liang et al. Oncotarget
- The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis
- (2017) Qiliang Peng et al. Oncotarget
- Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study
- (2017) Ronan T Gray et al. Clinical and Translational Gastroenterology
- Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis
- (2017) Jiayun Nian et al. Clinical and Translational Gastroenterology
- NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
- (2017) Phillip G. Febbo et al. Journal of the National Comprehensive Cancer Network
- IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers
- (2016) Tao Fu et al. ANNALS OF SURGERY
- Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer
- (2016) Michael S Lee et al. BRITISH JOURNAL OF CANCER
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- Regulation of H-Ras-driven MAPK signaling, transformation and tumorigenesis, but not PI3K signaling and tumor progression, by plasma membrane microdomains
- (2016) J V Michael et al. Oncogenesis
- Colorectal cancer carcinogenesis: a review of mechanisms
- (2016) Kanwal Tariq et al. Cancer Biology & Medicine
- Sporadic Microsatellite Instability-High Colon Cancers Rarely Display Immunohistochemical Evidence of Wnt Signaling Activation
- (2015) Nicole C. Panarelli et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis
- (2015) Filippo Pietrantonio et al. EUROPEAN JOURNAL OF CANCER
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies
- (2015) Eugenia R. Zanella et al. Science Translational Medicine
- PIK3CA Mutation in Colorectal Cancer: Relationship with Genetic and Epigenetic Alterations
- (2015) Katsuhiko Nosho et al. NEOPLASIA
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147
- (2014) Wilson I. Gonsalves et al. JNCI-Journal of the National Cancer Institute
- IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer
- (2014) Lucia Perez-Carbonell et al. PLoS One
- Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer
- (2014) Fabio Coppedè WORLD JOURNAL OF GASTROENTEROLOGY
- APC Polymorphisms and the Risk of Colorectal Neoplasia: A HuGE Review and Meta-Analysis
- (2013) Jing Liang et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- MicroRNAs in Cancer
- (2013) Gianpiero Di Leva et al. Annual Review of Pathology-Mechanisms of Disease
- Promoter CpG Island Hypermethylation of the DNA Repair Enzyme MGMT Predicts Clinical Response to Dacarbazine in a Phase II Study for Metastatic Colorectal Cancer
- (2013) A. Amatu et al. CLINICAL CANCER RESEARCH
- The prognostic significance ofAPCgene mutation and miR-21 expression in advanced-stage colorectal cancer
- (2013) T.-H. Chen et al. Colorectal Disease
- Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
- (2013) Enric Domingo et al. JOURNAL OF CLINICAL ONCOLOGY
- Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer
- (2013) TaeJeong Oh et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Prognostic Role of p53 Messenger Ribonucleic Acid Expression in Patients after Curative Resection for Stage I to III Colorectal Cancer: Association with Colon Cancer Stem Cell Markers
- (2013) Jung Wook Huh et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival
- (2013) Christophe Rosty et al. PLoS One
- NDST4 Is a Novel Candidate Tumor Suppressor Gene at Chromosome 4q26 and Its Genetic Loss Predicts Adverse Prognosis in Colorectal Cancer
- (2013) Sheng-Tai Tzeng et al. PLoS One
- Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS
- (2013) Deniz Tural et al. TUMOR BIOLOGY
- Laparoscopic vs. open approach for colorectal cancer: evolution over time of minimal invasive surgery
- (2013) Antonio Biondi et al. BMC Surgery
- Health related quality of life in colorectal cancer patients: state of the art
- (2013) Stefano Marventano et al. BMC Surgery
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
- (2012) Jueng Soo You et al. CANCER CELL
- BRAF Mutations in Colorectal Cancer Are Associated With Distinct Clinical Characteristics and Worse Prognosis
- (2012) Matthew F. Kalady et al. DISEASES OF THE COLON & RECTUM
- Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
- (2012) Carsten Bokemeyer et al. EUROPEAN JOURNAL OF CANCER
- MicroRNA-21 gene and cancer
- (2012) Yong Huang et al. MEDICAL ONCOLOGY
- Melanoma genome sequencing reveals frequent PREX2 mutations
- (2012) Michael F. Berger et al. NATURE
- TFAP2E–DKK4and Chemoresistance in Colorectal Cancer
- (2012) Matthias P.A. Ebert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-Scale Discovery of DNA-Methylation Biomarkers for Blood-Based Detection of Colorectal Cancer
- (2012) Christopher P. E. Lange et al. PLoS One
- BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
- (2011) T Yokota et al. BRITISH JOURNAL OF CANCER
- Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
- (2011) Francesco Crea et al. DRUG RESISTANCE UPDATES
- Genetics, Cytogenetics, and Epigenetics of Colorectal Cancer
- (2011) Lucia Migliore et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells
- (2010) T. Aleksic et al. CANCER RESEARCH
- Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
- (2010) Sergio Rizzo et al. CANCER TREATMENT REVIEWS
- Amplification of thymidylate synthetase in metastatic colorectal cancer patients pretreated with 5-fluorouracil-based chemotherapy
- (2010) Roshawn G. Watson et al. EUROPEAN JOURNAL OF CANCER
- Micromarkers: miRNAs in cancer diagnosis and prognosis
- (2010) Manuela Ferracin et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Microsatellite Instability in Colorectal Cancer
- (2010) C. Richard Boland et al. GASTROENTEROLOGY
- Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAFV600E mutation
- (2010) Jeanne Tie et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Relevance of KRAS in Human Cancers
- (2010) Sylwia Jančík et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
- (2010) Daniel J. Sargent et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis
- (2010) Chen Mao et al. MOLECULAR BIOLOGY REPORTS
- A Review of the Most Promising Biomarkers in Colorectal Cancer: One Step Closer to Targeted Therapy
- (2010) V. Deschoolmeester et al. ONCOLOGIST
- Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation
- (2010) Sun Lee et al. PATHOLOGY INTERNATIONAL
- MicroRNAs in diagnosis and prognosis in cancer: what does the future hold?
- (2010) Patrick Nana-Sinkam et al. PHARMACOGENOMICS
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma
- (2009) Ki-Seok Jang et al. HISTOPATHOLOGY
- KRASandBRAFMutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
- (2009) Susan D. Richman et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
- (2009) Pierre Laurent-Puig et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- FrequentPIK3CAgene amplification and its clinical significance in colorectal cancer
- (2009) Zeenath Jehan et al. JOURNAL OF PATHOLOGY
- Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers
- (2009) Jung Ho Kim et al. VIRCHOWS ARCHIV
- A Simplified, Noninvasive Stool DNA Test for Colorectal Cancer Detection
- (2008) Steven Itzkowitz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival
- (2008) Hirozumi Sawai et al. BMC GASTROENTEROLOGY
- SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2′deoxycytidine to increase SPARC expression and improve therapy response
- (2008) S Cheetham et al. BRITISH JOURNAL OF CANCER
- Immunohistochemistry versus Microsatellite Instability Testing for Screening Colorectal Cancer Patients at Risk for Hereditary Nonpolyposis Colorectal Cancer Syndrome
- (2008) Liying Zhang JOURNAL OF MOLECULAR DIAGNOSTICS
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Helical domain and kinase domain mutations in p110 of phosphatidylinositol 3-kinase induce gain of function by different mechanisms
- (2008) L. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started